Glaxosmi.-Pharma Stock/Share Prices, Buy and Sell Glaxosmi.-Pharma NSE Stocks

Glaxosmithkline Pharmaceuticals Ltd NSE / BSE
Pharmaceuticals, Large Cap

Invest

21 May 2018 | 04:15 PM

2,376.60

-21.55 (-0.90%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-2.92%

Return (1Y)

Underperformed Nifty 500 by 13.53%
More Volatile

0.99%

Standard Deviation (1Y)

Higher than Nifty 500 by 0.31%
Not so consistent

6/12

Months

underperformed Nifty 500
AxisDirect View

No View

52 Week High-Low

2,700

2,020

News & Announcements

Glaxosmithkline Pharmaceuticals to consider Accounts
21 days ago

Glaxosmithkline Pharmaceuticals to consider Accounts

30 - Apr - 2018 12:00 AM | 21 days ago

Glaxosmithkline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 24 May 2018, inter alia, to consider, approval of audited financial results (Standalone & Consolidated) for the quarter / year ended March 31, 2018 and to recommend dividend, if any, on the equity shares of the Company.
Powered by Capital Market - Live News
GlaxoSmithKline Pharmaceuticals to discuss results
53 days ago

GlaxoSmithKline Pharmaceuticals to discuss results

29 - Mar - 2018 12:00 AM | 53 days ago

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 24 May 2018 approval and declaration of Audited Financial Results for the year ended 31st March, 2018
Powered by Capital Market - Live News
Glaxosmithkline Pharmaceuticals announces cessation of director
66 days ago

Glaxosmithkline Pharmaceuticals announces cessation of director

16 - Mar - 2018 12:00 AM | 66 days ago

Glaxosmithkline Pharmaceuticals announced that Andrew Aristidou, Executive Director & CFO has ceased to be a Director & CFO of the Company from close of the business hours on 31 December, 2017.
Powered by Capital Market - Live News
Glaxosmithkline Pharmaceuticals standalone net profit rises 69.39% in the December 2017 quarter
107 days ago

Glaxosmithkline Pharmaceuticals standalone net profit rises 69.39% in the December 2017 quarter

03 - Feb - 2018 12:00 AM | 107 days ago

Net profit of Glaxosmithkline Pharmaceuticals rose 69.39% to Rs 89.69 crore in the quarter ended December 2017 as against Rs 52.95 crore during the previous quarter ended December 2016. Sales declined 0.35% to Rs 703.91 crore in the quarter ended December 2017 as against Rs 706.38 crore during the previous quarter ended December 2016.
Particulars Quarter Ended
Dec. 2017 Dec. 2016 % Var.
Sales 703.91 706.38 0
OPM % 20.15 7.38 -
PBDT 153.76 66.88 130
PBT 140.38 60.27 133
NP 89.69 52.95 69
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Glaxosmithkline Pharma Ltd has given the 2nd best dividend yield 1.83 for 1 Year among stocks in Pharmaceuticals Sector
MF shareholding in Glaxosmithkline Pharma Ltd has increased by 14.07% since past 3 Months
FII shareholding in Glaxosmithkline Pharma Ltd has decreased by -10.66% since past 1 Year
MF shareholding in Glaxosmithkline Pharma Ltd has increased by 33.8% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2017	Dec. 2016	% Var.
Sales	703.91	706.38	0
OPM %	20.15	7.38	-
PBDT	153.76	66.88	130
PBT	140.38	60.27	133
NP	89.69	52.95	69

General Notifications

My Notifications

Research Notifications

Glaxosmithkline Pharmaceuticals Ltd NSE / BSE Pharmaceuticals, Large Cap

2,376.60 -21.55 (-0.90%)

News & Announcements

Price vs Volume

Stock Trivia

Glaxosmithkline Pharmaceuticals Ltd NSE / BSE
Pharmaceuticals, Large Cap

2,376.60

-21.55 (-0.90%)